No Data
No Data
10-Q: Q2 2025 Earnings Report
8-K: Roivant Reports Financial Results for the Second Quarter Ended September 30, 2024, and Provides Business Update
Roivant to Report Financial Results for the Second Quarter Ended September 30, 2024 and Provide Business Update on Tuesday, November 12, 2024
Form 144 | Roivant Sciences(ROIV.US) Director Proposes to Sell 11.66 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Sep 25, $Roivant Sciences(ROIV.US)$、$ROIVANT SCIENCES LTD C/WTS 30/09/2026 (TO PUR COM)(ROIVW.US)$ Director DANIEL GOLD & LAURA GOLD intends to sell 991.59K shares of its
Form 144 | Roivant Sciences(ROIV.US) Director Proposes to Sell 18.2 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Sep 24, $Roivant Sciences(ROIV.US)$、$ROIVANT SCIENCES LTD C/WTS 30/09/2026 (TO PUR COM)(ROIVW.US)$ Director DANIEL GOLD &LAURA GOLD JT TEN intends to sell 1.57 million shares
Form 144 | Roivant Sciences(ROIV.US) Director Proposes to Sell 3.14 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Sep 24, $Roivant Sciences(ROIV.US)$、$ROIVANT SCIENCES LTD C/WTS 30/09/2026 (TO PUR COM)(ROIVW.US)$ Director RIOJA DOLCE LLC intends to sell 269.71K shares of its common stock
No Data
No Data